December 2023

Addinex was one of only four companies accepted into the Mount Sinai Innovation Partners Elementa Labs program where we are working with our internal champion, the Chief of General Surgery at Mount Sinai Hospital, on several commercialization projects.

May 2023

Yale School of Medicine survey of 146 psychiatrists with experience in addiction medicine showed 91% of doctors expressing that they were encouraged by the availability of the Addinex system, 75% deeming the system very or extremely useful, and 65% stating that they would prescribe it with another 30% needing more information before they would do so.

March 2023

Columbia University Medical Center launches second Addinex study, "Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and to Reduce Refills After Cancer-Related Surgery."

September 2022

Addinex Technologies Awarded $260K Grant by the CDC to Improve Addiction Medication Dispensing.

July 2022

Addinex Technologies' Success in Decreasing Opioid Refills and Increasing Disposal of Excess Pills After Surgery Validated in Clinical Study by Columbia University Medical Center.

May 2022

Addinex Technologies, Inc. Named Finalist in Health Category of Fast Company’s 2022 World Changing Ideas Awards.